Searchable abstracts of presentations at key conferences in endocrinology

ea0012p53 | Diabetes, metabolism and cardiovascular | SFE2006

Proglucagon processing can be altered to produce GLP-1 in pancreatic alpha cells

James NM , Pritchard LE , Brennand JC , White A

The proglucagon-derived hormone, glucagon-like peptideĀ–1 (GLP-1), augments both beta cell function and mass. However, GLP-1 is rapidly degraded in plasma, thereby limiting its potential as a treatment for diabetes. One approach to circumvent this problem would be to stimulate synthesis of GLP-1 locally in the islet.Emerging evidence suggests that pancreatic alpha cells, which normally produce glucagon, can adapt to produce GLP-1. This phenomenon may...

ea0012p114 | Reproduction | SFE2006

Effect of serum testosterone concentrations on outcome of induction of ovulation by low-dose FSH in women with polycystic ovary syndrome (PCOS)

Gorry Anwen , White Davinia , Franks Stephen

The recent recommendations from the joint ESHRE/ASRM expert panel regarding the definition of PCOS (the so-called Rotterdam Criteria) have given rise to considerable controversy, particularly over the inclusion of anovulatory women with polycystic ovaries (PCO) but without evidence of androgen excess. We reviewed the results of a large series of anovulatory women with PCO who have been treated with low-dose FSH at our centre with the aim of investigating the impact of serum te...

ea0010oc19 | Young Endocrinologist session | SFE2005

Characterisation of a novel glucocorticoid-interacting protein expressed in human cancers that modulates glucocorticoid sensitivity

Rice L , #Waters|# , #Garside|# , #Ray|# , White A

Glucocorticoids (Gcs) act through the ubiquitously expressed glucocorticoid receptor (GR). Transcriptional activation by the GR involves interaction with co-modulator proteins, the expression level of which can mediate Gc sensitivity. The aim of this study was to identify additional GR interacting proteins that may influence Gc sensitivity.Using a yeast two-hybrid screen we identified a novel GR interacting protein, R59, which showed an enhanced interact...

ea0009p16 | Diabetes and metabolism | BES2005

Hypothalamic expression of the glucose sensing KATP channel component Kir 6.2 is altered in animal models of obesity and diabetes

Gyte A , Pritchard L , Brennand J , White A

Neuronal glucose and insulin signals are integrated by hypothalamic neurons to regulate energy balance. These signalling mechanisms are not clearly defined in the hypothalamus, and may be altered in obesity and diabetes. This study aimed to analyse quantitatively hypothalamic expression of candidate genes in signal transduction pathways and investigate dysregulation using Zucker and Zucker Diabetic Fatty (ZDF) models.Taqman RT-PCR was used to compare exp...

ea0009p142 | Steroids | BES2005

Medication management and quality of life in patients with primary adrenal insufficiency

White K , Wass J , Elliott A , Baker S

Primary adrenal insufficiency is a relatively rare endocrine condition requiring life-long glucocorticoid and mineralcorticoid replacement therapy. Unlike other endocrine conditions - such as diabetes - complications associated with early mortality are unusual and well-medicated patients can expect to have a normal life span. Nevertheless, patients typically report a variety of symptoms which reduce their quality of life.Data from an international survey...

ea0007p59 | Diabetes, metabolism and cardiovascular | BES2004

Quantitative analysis of glucose and insulin sensing genes in the hypothalami of Zucker Diabetic Fatty (ZDF) rats

Gyte A , Pritchard L , Brennand J , White A

Peripheral metabolic signals such as leptin, glucose and insulin are integrated by neurons in the hypothalamus to regulate both short and long term energy balance. However, the signal transduction mechanisms by which neurons sense glucose and insulin levels are unclear and specific parts of the pathways may be distinct from those in the pancreas. The aim of this study was to quantitatively analyse hypothalamic expression of genes known to be involved in pancreatic glucose/insu...

ea0003oc21 | Growth Regulation | BES2002

Decidual matrix metalloproteases MMP-3 and MMP-9 proteolyse insulin-like growth factor binding protein-1

Coppock H , Aplin J , White A , Westwood M

Growth in utero depends on adequate development and function of the fetal / maternal interface. During pregnancy, the insulin-like growth factors (IGFs), which are known to be critically involved in placental development, are controlled by a binding protein - IGFBP-1 - produced by maternal decidualised endometrium. We have recently found that decidua also produces a protease which cleaves IGFBP-1 into fragments that are unable to bind ligand. This study aimed to identif...

ea0094p152 | Nursing Practice | SFEBES2023

Outcomes of a self-reported knowledge survey on the management of adrenal insufficiency within a local accident and emergency Department

White Katherine , Kaucha Rana Anita , Falconer Emily

Background: Evidence shows that in an emergency, prompt and appropriate treatment of patients with adrenal insufficiency (AI) significantly improves outcomes and mortality risk. However, patient feedback and evidence suggest shortfalls in care and treatment of AI due to lack of knowledge and understanding from clinical staff. The aim of this survey was to explore frontline nursing knowledge and understanding of AI, to identify gaps for future training purposes...

ea0062p24 | Poster Presentations | EU2019

First paraganglioma identified on surveillance screening in an asymptomatic SDHA germline mutation carrier

White Gemma , Tufton Nicola , Adams Ashok , Akker Scott

Case history: We present the case of a 72-year-old female who was referred to the endocrinology service following the identification of a pathogenic germline mutation in the SDHA gene (c.91C>T, p.Arg32*) as part of a genetic panel for hypertrophic cardiomyopathy. There was no personal or family history of phaeochromocytoma or paraganglioma (PPGL), gastrointestinal stromal tumours or pituitary adenoma.Investigations: Our patient was reviewed ...

ea0038p368 | Reproduction | SFEBES2015

Low-dose gonadotrophin therapy for induction of ovulation: comparison of results in women with PCOS or hypothalamic amenorrhoea

Lovelock Suzie , Hardy Kate , White Davinia , Franks Stephen

We have reviewed the outcome of a low-dose step-up regimen for induction of ovulation in clomiphene-unresponsive women with PCOS and in women with hypothalamic hypogonadism (HH), treated at a single centre. Data from 366 women with PCOS and 80 with HH (1165 records) were entered into a FileMakerPro database, refined and constrained to allow stratification and analysis of relevant data. 85% of cycles were ovulatory in both PCOS and HH. PCOS patients were more likely to have cyc...